Sequential changes in gene expression profiles in breast cancers during treatment with the aromatase inhibitor, letrozole
Authors:
- W R MillerWMW R Miller
- A LarionovALA Larionov
- T J AndersonTAT J Anderson
- D B EvansDED B Evans
- J M DixonJDJ M Dixon
- 10 August 2010
- journal article
- Published by Springer Nature in The Pharmacogenomics Journal
- Vol. 12 (1) , 10-21
Abstract
The Pharmacogenomics Journal is dedicated to the rapid publication of original research on basic pharmacogenomics research and its clinical applications.Keywords
This publication has 19 references indexed in Scilit:
- Gene Expression Profiles Differentiating Between Breast Cancers Clinically Responsive or Resistant to LetrozoleJournal of Clinical Oncology, 2009
- arrayQualityMetrics—a bioconductor package for quality assessment of microarray dataBioinformatics, 2008
- GOEAST: a web-based software toolkit for Gene Ontology enrichment analysisNucleic Acids Research, 2008
- Changes in breast cancer transcriptional profiles after treatment with the aromatase inhibitor, letrozolePharmacogenetics and Genomics, 2007
- Proliferation, steroid receptors and clinical/pathological response in breast cancer treated with letrozoleBritish Journal of Cancer, 2006
- Open source clustering softwareBioinformatics, 2004
- Linear Models and Empirical Bayes Methods for Assessing Differential Expression in Microarray ExperimentsStatistical Applications in Genetics and Molecular Biology, 2004
- A Randomized Trial of Letrozole in Postmenopausal Women after Five Years of Tamoxifen Therapy for Early-Stage Breast CancerNew England Journal of Medicine, 2003
- An open randomised trial of second-line endocrine therapy in advanced breast cancerEuropean Journal of Cancer, 2003
- Exploration, normalization, and summaries of high density oligonucleotide array probe level dataBiostatistics, 2003